- 28 July 2021 CRISPR gene editing in pluripotent stem cells reveals the function of MBNL proteins during human in vitro myogenesis
- 26 July 2021 Hutchinson-Gilford progeria syndrome: Rejuvenating old drugs to fight accelerated ageing
- 26 July 2021 AAV2/9-mediated silencing of PMP22 prevents the development of pathological features in a rat model of Charcot-Marie-Tooth disease 1 A
Created in 2005 through a collaboration between Inserm – National Institute of Health and Medical Research – and AFM-Telethon – French Association against Myopathies – I-Stem is the largest French laboratory for research and development dedicated to human pluripotent stem cells, of embryonic origin or obtained by reprogramming gene.
I-Stem is part of the Biotherapy Institute for Rare Diseases, which includes so far the three centers of research and development funded directly by the AFM Telethon. (Read more…)